Your browser doesn't support javascript.
loading
Who on IRF are you? IRF8 deficiency redirects cDC1 lineage commitment.
Waller, Kathryn; Scott, Charlotte L.
Afiliação
  • Waller K; Laboratory of Myeloid Cell Biology in Tissue Damage and Inflammation, VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Faculty of Sciences, Ghent University, Ghent, Belgium.
  • Scott CL; Laboratory of Myeloid Cell Biology in Tissue Damage and Inflammation, VIB Center for Inflammation Research, Ghent, Belgium; Department of Biomedical Molecular Biology, Faculty of Sciences, Ghent University, Ghent, Belgium; Department of Chemical Sciences, Bernal Institute, University of Limerick, Castletroy, Limerick, Ireland. Electronic address: charlotte.scott@ugent.be.
Trends Immunol ; 43(9): 687-689, 2022 09.
Article em En | MEDLINE | ID: mdl-35963772
ABSTRACT
Interferon regulatory factor 8 (IRF8) has long been associated with conventional dendritic cell type I (cDC1) development. In a recent study, Lança et al. demonstrate that IRF8 is also crucial in cells already committed to the cDC1 lineage. Here, deletion of IRF8 from the XCR1-expressing pre-cDC1 stage onward leads to a loss of commitment and reprogramming of the cells toward a cDC2-like phenotype.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Fatores Reguladores de Interferon Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Fatores Reguladores de Interferon Idioma: En Ano de publicação: 2022 Tipo de documento: Article